Inventor · disambiguated record
Paul William Thompson
Also filed as: THOMPSON PAUL · THOMPSON PAUL WILLIAM
2 granted patents·7 pending applications·611 citations·filing 1990–2021
75Inventor score
Top patents by PatentIndex Score
9 records- 0191US5237987AHuman lung ventilator systemINFRASONICS INC·Filed 1990·Granted Aug 24, 1993·414 cites·6 claims
- 0280US5452714AHuman lung ventilator systemINFRASONICS INC·Filed 1993·Granted Sep 26, 1995·197 cites·12 claims
- 0354US2023219939A1N-(1-cyano-pyrrolidin-3-yl)-5-(3-(trifluoromethyl)phenyl)oxazole-2-carboxamide derivatives and the corresponding oxadiazole derivatives as usp30 inhibitors for the treatment of mitochondrial dysfunctionMISSION THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0454US2023312580A11-(5-(2-cyanopyridin-4-yl)oxazole-2-carbonyl)-4-methylhexahydropyrrolo[3,4-b]pyr role-5(1h)-carbonitrile as usp30 inhibitor for use in the treatment of mitochondrial dysfunction, cancer and fibrosisMISSION THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0554US2023303547A1N-cyanopyrrolidines with activity as usp30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0653US2023119013A1N-cyanopyrrolidines with activity as usp30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0750US2022315572A1Substituted cyanopyrrolidines with activity as usp30 inhibitorsMISSION THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0848US2023233500A1Gasdermin D (GSDMD) Succination for the Treatment of Inflammatory DiseaseUNIV MASSACHUSETTS·Filed 2021·Application pending·0 cites
- 0941US2021002262A1Cyanopyrrolidines as usp30 inhibitors and fibrosis treatmentMISSION THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul William Thompson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →